Need more news to keep us in the 200 before Sept… I expect they have bitten off too much this time. Will find out next week first to cover will get the best prices.
CEO aligned with DW would be nice for a change. RE should just take the job and just keep pumping sales fingers crossed they can make up for the slower first half.
Should get a rerate after FY report rev numbers seem low for next year current RR is 13M is 156M with no growth 160M forecast…
Betacell trial could give a decent wildcard. Would have liked to know if BARDA submission is done or close too. June was the plan for memory?
Is that submission data enough for Japan entry or do they need the response from the FDA. I think it’s the latter but not sure.
PNV Price at posting:
$1.31 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)